The new guidelines say three-stage safety trials of conventional COVID-19 vaccines are not necessary for vaccine modifications. But the manufacturing company must provide clear evidence that Vaccine customize Can stimulate the immune response
Chief Scientific Officer at the Drug and Healthcare Regulatory Authority Christian Schneider said: “People can be confident that we will not approve the vaccine until it meets the high expectations of safety, quality and effectiveness standards.”
– .